New anhydrous lactose from Borculo Domo

- Last updated on GMT

Related tags: Pharmacology

Borculo Domo has extended its range of lactose products for
pharmaceutical applications with the launch of a new anhydrous
version.

Lactose is widely used as a filler or filler-binder in the manufacture of pharmaceutical tablets and capsules, and the anhydrous form is particularly used when direct compression tabletting is being used. The latter is characterised by superior dissolution and binding properties and is especially useful for moisture sensitive actives.

Borculo Domo​ said its new Lactopress Anhydrous 250 has binding properties that make production of tablets by direct compression more efficient. This enables pharmaceutical companies to save costs in their tabletting process, it added.

Anhydrous lactose is dried at high temperatures on a roller dryer. This production process results in a product that does not contain crystal water, and this is what makes it a suitable excipient for moisture sensitive formulations.

Borculo Domo said the new product will now be launched in more than 50 countries worldwide. The launch comes just a few months after the introduction of Lactopress Spraydried 250.

Related news

Show more

Related products

show more

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

SQ-USP-Brochure-Thumb-AP-CC

NEW…sugarcane derived USP Squalane from Aprinnova

APRINNOVA – A joint venture of AMYRIS and NIKKOL Group | 26-Feb-2018 | Product Brochure

To date, topical formulation chemists have been restricted to using Squalane derived from the harvesting of shark livers. Neossance Squalane USP, derived...

Related suppliers

Follow us

Products

View more

Webinars